drugset / Trial / NCT02882438

Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis

NCT02882438

Phase 1 Unknown 30 enrolled Al-Azhar University
RandomizedParallel-groupSingle-blindTreatment

Summary

Tinea Pedis infected the feet of about 20-25% of the world population. Tinea Pedis is a fungal infection of the feet and it is easily spread. Oral therapy is usually used for chronic conditions or when topical treatment has failed. The aim of this study is to prove the antifungal and antibacterial activity of Ginko Biloba (GKB) \& Glucosamine (GL) as separate material or both in combination.

Timeline

Start
2016-01
Primary completion
2020-09
Completion
2022-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginkgo Biloba Extract Traditional medicine (herbal / TCM) Oral

Indications